Discover trends, market shifts, and competitive outlooks for the cancer profiling industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Cancer Profiling Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for cancer profiling has experienced swift expansion in the recent past. The forecasts predict an increase from $13.48 billion in 2024 to $15.05 billion in 2025, showing a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth during the historic period include the surge in cancer cases, adoption of precision medicine methods, clinical utilization of biomarkers, development of drugs and targeted treatments, enhanced awareness, and activism by patients.

In the coming years, the market size for cancer profiling is predicted to grow rapidly. By 2029, it is projected to reach $23.08 billion, moving at a compound annual growth rate (CAGR) of 11.3%. The anticipated expansion within this period can be traced back to factors such as the employment of artificial intelligence, research collaborations globally, expanded use of liquid biopsy, support from regulatory bodies for precision medicine, and an increased emphasis placed on early detection. Expect to see trends like dominance of liquid biopsy, extensive genomic profiling, the emergence of immunoprofiling, cooperative data sharing networks, and single-cell sequencing during this forecast period.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Cancer Profiling Market?

The upward trend in cancer occurrences is likely to fuel the expansion of the cancer profiling market in the future. Cancer incidence denotes the count of fresh cancer cases within a certain population over a given timeframe. This rising incidence is attributed to factors such as urbanization, an increasing elderly population, lifestyle transformations, as well as environmental and genetic influences. Cancer profiling is instrumental in pinpointing specific molecular or genetic alterations in a tumor, like gene mutations or other tumor DNA changes, which proves valuable in the course of cancer treatment. For example, as per the American Cancer Society—a US-based volunteer group—in 2022, the predicted count of new cancer diagnoses and death toll was around 1.9 million and 609,360 respectively, in the United States. Hence, the escalating rates of cancer is serving as a driving force for the growth of the cancer profiling market.

Which Key Market Segments Comprise the Cancer Profiling Market and Drive Its Revenue Growth?

The cancer profiling market covered in this report is segmented –

1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization

2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers

4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications

Subsegments:

1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Luminex xMAP Technology, Radioimmunoassays

2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR)

3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq)

4) By Microarrays: DNA Microarrays, RNA Microarrays, SNP Arrays

5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9912&type=smp

Which Areas Are Leading Regions in the Cancer Profiling Market Expansion Across the Globe?

North America was the largest region in the cancer profiling market in 2024. The regions covered in the cancer profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in the Cancer Profiling Market Over the Coming Years?

Leading businesses in the cancer profiling market are making strides towards innovation with a focus on broad coverage. This type of testing investigates 517 genes that are significant to cancer in about 30 solid tumor types. Broad coverage involves a thorough review of a diverse assortment of genetic mutations, biomarkers, and molecular targets. For example, Illumina, Inc., a biotechnology firm based in the United States, introduced the TruSight Oncology Comprehensive (TSO) test in March 2022, which is a major breakthrough in cancer diagnosis. This new in vitro diagnostic test in Europe maps cancer mutations, directing patients towards targeted treatments. It scrutinizes 517 genes within almost 30 distinct types of solid tumors, examining both DNA and RNA. With results delivered within a span of four to five days, it accelerates the process and boasts a CE-mark for European quality standards, mitigating the need for multiple gene tests on various tissue specimens.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

How Is the Cancer Profiling Market Conceptually Defined?

Cancer profiling refers to a diagnostic procedure that is conducted to analyze the genetic information of tumor cells in the body. It provides information about certain molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model